Engineered Virus Steals Proteins From H.I.V., Pointing to New …
网页2024年8月8日 · For decades, scientists have developed drugs for H.I.V. that attack the virus itself. Some drugs, for example, prevent a protein called a protease from activating H.I.V.
HIV: how close are we to a vaccine — or a cure? - Nature
网页2024年9月2日 · Longer-term solutions are in the works. But how close are we to a cure for HIV — or a vaccine? Nature spoke with specialists to find out. What advances have been made in the treatment of HIV?
A two-dose schedule could make HIV vaccines more effective
网页6 天之前 · Each year, HIV infects more than 1 million people around the world, and some of those people do not have access to antiviral drugs. An effective vaccine could prevent many of those infections. One promising vaccine now in clinical trials consists of an HIV protein called an envelope trimer, along with a nanoparticle called SMNP.
Twice-yearly shot proves successful at preventing HIV infection …
网页2024年7月24日 · Two shots a year of a drug currently used to treat HIV infections were dramatically effective at preventing infections in a study among young women and adolescent girls in Africa.
New HIV drug can only offer hope of ending AIDS if all have …
网页GENEVA, 10 July 2024— UNAIDS has welcomed the release of Gilead Sciences’ trial results on the injectable long-acting HIV medicine Lenacapavir for HIV prevention. The …
After decades of failures, researchers have renewed hopes for an ...
网页2024年3月6日 · Despite 20 years of failures in major HIV vaccine trials, researchers say recent advances have likely, hopefully, put them on the right track to develop a highly effective vaccine.
Researchers determine a two-dose schedule could make HIV …
网页6 天之前 · Each year, HIV infects more than 1 million people around the world, and some of those people do not have access to antiviral drugs. An effective vaccine could prevent many of those infections.
Long-Acting Drugs May Revolutionize H.I.V. Prevention and …
网页2024年4月17日 · A pill taken once a week. A shot administered at home once a month. Even a jab given at a clinic every six months. In the next five to 10 years, these options may be available to prevent or treat ...
Gileads Twice Yearly Lenacapavir Demonstrated 100 Efficacy and ...
网页2024年6月20日 · FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced topline results from an interim analysis of its pivotal, Phase 3 PURPOSE 1 trial indicating that the company’s twice-yearly injectable HIV-1 capsid inhibitor, lenacapavir, demonstrated 100% efficacy for the investigational use of HIV prevention in cisgender women.
Gilead Shot Provides Total Protection From HIV in Trial of Young ...
网页Researchers and activists in the trenches of the long fight against H.I.V. got a rare piece of exciting news this week: Results from a large clinical trial in Africa showed that a twice …